Results 241 to 250 of about 8,739,134 (290)

Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease

open access: yesFEBS Open Bio, EarlyView.
Repair of neuronal DNA damage in Alzheimer's disease by KCL‐286. (A) Amyloid‐β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double‐strand breaks and glial activation. (B) KCL‐286 activates RARβ/RXR signalling via retinoic acid response elements (RAREs), associated with increased BRCA1 expression, enhanced DNA repair and ...
Natasha Hill   +6 more
wiley   +1 more source

Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer's disease. [PDF]

open access: yesNat Aging
Bhattarai P   +41 more
europepmc   +1 more source

Prediction of the properties of sintered copper-graphite composites using response surface methodology. [PDF]

open access: yesPLoS One
Ankit   +8 more
europepmc   +1 more source

CCL7-CCR3 signaling mediates olfactory dysfunction in a mouse model of allergic rhinitis. [PDF]

open access: yesFront Immunol
Yang T   +10 more
europepmc   +1 more source

Interpreting Heterogeneity Beyond I<sup>2</sup> in Meta-Analysis: Integrating Statistical Metrics With Clinical Judgement. [PDF]

open access: yesJ Eval Clin Pract
Ferreira MHL   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy